Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Six policy lessons relevant to cannabis legalization
Chelsea L. Shover, Keith Humphreys
The American Journal of Drug and Alcohol Abuse (2019) Vol. 45, Iss. 6, pp. 698-706
Open Access | Times Cited: 70

Showing 26-50 of 70 citing articles:

Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth?
Kristine Rømer Thomsen, Birgitte Thylstrup, Emily A. Kenyon, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 132, pp. 169-180
Open Access | Times Cited: 13
Pharmacists’ perceptions and experiences of medicinal cannabis dispensing: A narrative review with a systematic approach
Que Sabmeethavorn, Yvonne Bonomo, Christine Mary Hallinan
International Journal of Pharmacy Practice (2022) Vol. 30, Iss. 3, pp. 204-214
Open Access | Times Cited: 9
Bridging Disciplines: Applications of Forensic Science and Industrial Hemp
Sheree J. Finley, Gulnaz T. Javan, Robert L. Green
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 9
Cannabis and Public Health: A Study Assessing Regular Cannabis Users Through Health Indicators
Javier Hidalgo Jiménez, Genís Oña, Miguel Ángel Alcázar‐Córcoles, et al.
Cannabis and Cannabinoid Research (2023) Vol. 9, Iss. 2, pp. 659-668
Closed Access | Times Cited: 5
Effects of cannabis regulation in Switzerland: Study protocol of a randomized controlled trial
Lavinia Baltes-Flueckiger, Regine Steinauer, Maximilian Meyer, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 5
Cannabis legalization: progress in harm reduction approaches for substance use and misuse
Bryon Adinoff, Ziva D. Cooper
The American Journal of Drug and Alcohol Abuse (2019) Vol. 45, Iss. 6, pp. 707-712
Open Access | Times Cited: 15
Patterns of recreational cannabis use in Aotearoa-New Zealand and their consequences: evidence to inform voters in the 2020 referendum
Richie Poulton, Kirsten Robertson, Joseph M. Boden, et al.
Journal of the Royal Society of New Zealand (2020) Vol. 50, Iss. 2, pp. 348-365
Open Access | Times Cited: 13
Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality
A.J. Carrascosa, Francisco Navarrete, Raquel Saldaña, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6268-6268
Open Access | Times Cited: 1
Canadian Cannabis Industry and Social Responsibility: The Case of Canopy Growth
Aaraón Díaz Mendiburo
Norteamérica (2024) Vol. 19, Iss. 2
Open Access | Times Cited: 1
A Review of Meta-Analyses of Prevention Strategies for Problematic Cannabis Use
Sharon E. O’Hara, Mallie J. Paschall, Joel W. Grube
Current Addiction Reports (2024) Vol. 11, Iss. 5, pp. 886-893
Closed Access | Times Cited: 1
The Role of the Cerebellum in Drug Reward: A Review
Yongbo Wang, Lan Yan
Journal of Integrative Neuroscience (2023) Vol. 22, Iss. 6
Open Access | Times Cited: 4
Identifying policy options to regulate high potency cannabis: A multiple stakeholder concept mapping study in Washington State, USA
Beatriz H. Carlini, Sharon B. Garrett, Patrick Matos, et al.
International Journal of Drug Policy (2023) Vol. 123, pp. 104270-104270
Closed Access | Times Cited: 4
The legalization of cannabinoid products and standardizing cannabis-drug development in the United States: a brief report
Jahan P. Marcu
Dialogues in Clinical Neuroscience (2020) Vol. 22, Iss. 3, pp. 289-293
Open Access | Times Cited: 11
Recreational cannabis legalization presents an opportunity to reduce the harms of the US medical cannabis industry
Keith Humphreys, Chelsea L. Shover
World Psychiatry (2020) Vol. 19, Iss. 2, pp. 191-192
Open Access | Times Cited: 8
Time Trends in the Co-use of Cannabis and the Misuse of Tranquilizers, Sedatives and Sleeping Pills among Young Adults in Spain between 2009 and 2015
Domingo Palacios‐Ceña, Isabel Jiménez‐Trujillo, Valentín Hernández‐Barrera, et al.
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 18, pp. 3423-3423
Open Access | Times Cited: 7
Risk factors for the onset of dependence and chronic psychosis due to cannabis use: Survey of patients with cannabis‐related psychiatric disorders
Toshihiko Matsumoto, Toshitaka Kawabata, Kyoji Okita, et al.
Neuropsychopharmacology Reports (2020) Vol. 40, Iss. 4, pp. 332-341
Open Access | Times Cited: 6
Cannabis Growers in the United States: Findings From a National Household Survey 2010−2014
Alejandro Azofeifa, Rosalie Liccardo Pacula, Margaret E. Mattson
Journal of Drug Issues (2021) Vol. 51, Iss. 3, pp. 518-530
Closed Access | Times Cited: 6
Predictors of perceived symptom change with acute cannabis use for mental health conditions in a naturalistic sample: A machine learning approach
Nirushi Kuhathasan, Pedro L. Ballester, Luciano Minuzzi, et al.
Comprehensive Psychiatry (2023) Vol. 122, pp. 152377-152377
Open Access | Times Cited: 2
Cannabislegalisierung in Deutschland – Implikationen aufgrund der Erfahrungen aus Uruguay, Kanada und den USA: ein narratives Review
Peter Neu
Fortschritte der Neurologie · Psychiatrie (2023) Vol. 91, Iss. 10, pp. 397-403
Closed Access | Times Cited: 2
Regulating Private and Public Places of Non-Medical Cannabis Consumption in North America: Public Health and Public Safety Issues
Camille Gourdet, François Gagnon, Craig W. Moscetti, et al.
Journal of Canadian Studies (2021) Vol. 55, Iss. 2, pp. 279-306
Closed Access | Times Cited: 5
An overview of global monitoring systems for the side effects and adverse events associated with medicinal cannabis use: A scoping review using a systematic approach
Rebecca Qi Wang, Yvonne Bonomo, Christine Mary Hallinan
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Is there anything beyond addiction psychotherapy in patients with cannabis use disorder? A rationale for prescribing medical marihuana as a harm reduction strategy
Gniewko Więckiewicz, Iga Stokłosa, Magdalena Piegza
Archives of Psychiatry and Psychotherapy (2024)
Open Access
Can They Keep Up? Fecundity, Pollen Fitness, and Reproductive Success in Subdioecious, Sexually Labile Cannabis Sativa L
Sydney B. Wizenberg
(2024)
Open Access
Can They Keep Up? Fecundity, Pollen Fitness, and Reproductive Success in Subdioecious, Sexually Labile Cannabis Sativa L
Sydney B. Wizenberg
(2024)
Open Access
Associations of Local Cannabis Control Policies With Harmful Cannabis Exposures Reported to the California Poison Control System
Ellicott C. Matthay, Leyla Mousli, Chloe Sun, et al.
Epidemiology (2024) Vol. 35, Iss. 4, pp. 447-457
Open Access

Scroll to top